Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03601507 Terminated - Clinical trials for HPV Positive Oropharyngeal Squamous Cell Carcinoma

Alpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer

Start date: March 11, 2019
Phase: Phase 2
Study type: Interventional

This phase II trial studies how well alpelisib works in treating participants with human papillomavirus(HPV)-associated stage I-IVA head and neck cancer that can be removed by surgery. Alpelisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

NCT ID: NCT03600948 Terminated - Clinical trials for Restenoses, Coronary

BIOFLOW-SV All Comers Registry

BIOFLOW-SV
Start date: August 27, 2018
Phase:
Study type: Observational

Assessment of the clinical safety and performance of the Orsiro drug-eluting stent in a real world setting in patients with small vessels with reference vessel diameter ≤2.75 mm.

NCT ID: NCT03600623 Terminated - Pancreatic Cancer Clinical Trials

Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

Start date: September 25, 2017
Phase: Early Phase 1
Study type: Interventional

This study will implement a new treatment regimen for patients with advanced and inoperable pancreatic cancer using chemotherapy combinations of Folfirinox or gemcitabine-nab paclitaxel (abraxane) followed by a short course of high dose radiation called Stereotactic Body Radiation Therapy (SBRT). While the chemotherapy is standard of care, the strategy of adding SBRT has not been investigated. An increase in the percentage of patients who can proceed to have surgery to remove their disease is anticipated with this approach.

NCT ID: NCT03600467 Terminated - Solid Tumor Clinical Trials

Activity of Seviteronel in Patients With Androgen Receptor (AR)-Positive Glioblastoma

START
Start date: August 13, 2018
Phase: Phase 2
Study type: Interventional

This study's purpose is to facilitate and expedite the clinical testing of SEVI-D in a population with advanced GBM that are androgen receptor (AR) positive. Who is it for? You may be eligible for this study if you have a GBM with clinical/radiological progression on or following last anticancer therapy. Study details: All participants will be screened to confirm if their GBM is AR positive by the study team. If eligible, participants will receive the medications of Serivteronel and Dexamethasone (also known as SEVI-D) by oral tablets continuously per cycle (4 weeks). Participants will be asked to have blood tests, scans, complete questionnaire and regularly meet with the study doctor and team. It is hoped this research will demonstrate this treatment could be beneficial for the treatment of GBM that are known to be human androgen receptor positive.

NCT ID: NCT03599336 Terminated - Arthropathy Clinical Trials

RSA vs. Nonop for 3 & 4-Part Proximal Humerus Fractures

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

There is currently no consensus amongst orthopedic specialists on the best way to treat 3- and 4-part proximal humerus fractures. No surgery and surgery with a type of shoulder replacement called a reverse total shoulder arthroplasty are two options that many orthopedists use. This study is being performed to evaluate the differences in short- and long-term pain and functional outcomes between patients who are treated with these two different options.

NCT ID: NCT03598036 Terminated - Clinical trials for Focal Segmental Glomerulosclerosis

Dose-Exploration Evaluating the Efficacy and Safety of Voclosporin in Subjects With Focal Segmental Glomerulosclerosis

AURONA™
Start date: June 21, 2018
Phase: Phase 2
Study type: Interventional

Evaluating the Efficacy and Safety of Voclosporin in Achieving Complete or Partial Remission of Proteinuria in Subjects with Focal Segmental Glomerulosclerosis

NCT ID: NCT03597503 Terminated - Clinical trials for Attention Deficit Hyperactivity Disorder

Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment

Start date: July 31, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this study was to evaluate the effect of SPN-810 for the treatment of impulsive aggression (IA) in adolescents diagnosed with ADHD when taken in conjunction with standard ADHD treatment.

NCT ID: NCT03597490 Terminated - Clinical trials for Partial Thickness Rotator Cuff Tear

Multimodal Physical Therapy With Exercise in Partial-thickness Rotator Cuff Tears

Start date: July 1, 2018
Phase:
Study type: Observational

The aim of this study is to investigate the early stage effectiveness of multimodal physical therapy with exercise in the conservative treatment of partial thickness rotator cuff tears.

NCT ID: NCT03597347 Terminated - Clinical trials for Mycobacterium Infections, Nontuberculous

Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection

ENCORE
Start date: June 20, 2019
Phase: Phase 2
Study type: Interventional

A study to evaluate the efficacy of inhaled molgramostim administered open-label to adult cystic fibrosis (CF) subjects with chronic pulmonary nontuberculous mycobacterial (NTM) infection, with or without ongoing antimycobacterial guideline based combination therapy.

NCT ID: NCT03594045 Terminated - Clinical trials for Heparin-induced Thrombocytopenia

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Start date: December 18, 2018
Phase: Phase 2
Study type: Interventional

This research study is studying a drug as a possible treatment for heparin induced thrombocytopenia (HIT) or Heparin-induced Thrombocytopenia and Thrombosis (HITT). The drug involved in this study is apixaban.